Results 121 to 130 of about 31,301 (226)

BRASH Syndrome

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT BRASH syndrome is a life‐threatening clinical entity characterized by Bradycardia, Renal failure, Atrioventricular (AV) blockade, Shock, and Hyperkalemia. This syndrome is often triggered in patients on AV nodal blocking agents who develop acute kidney injury, leading to a “vicious cycle” of worsening bradycardia and renal dysfunction.
Sowdo Nur Iyow   +4 more
wiley   +1 more source

Superior palatability of crushed lercanidipine compared with amlodipine among children

open access: yes, 2010
To compare the taste of equivalent doses of pulverized amlodipine and lercanidipine, two calcium channel blockers, among children with kidney ...
Milani, Gregorio   +17 more
core   +1 more source

A Case Report of PR Interval Prolongation Caused by Amlodipine

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Amlodipine is a widely used dihydropyridine calcium channel blocker. Its effects on the cardiac conduction system, especially PR interval prolongation, are rare but clinically important. We report a 25‐year‐old healthy male subject in a clinical trial with baseline first‐degree atrioventricular block (PR interval 230 ms).
Zhiying Fu   +3 more
wiley   +1 more source

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives

open access: yes, 2009
Madhuri Devabhaktuni1, Sripal Bangalore21Department of Medicine, Division of Cardiology, St Luke’s Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA; 2Brigham and Women’s Hospital, Harvard ...
Sripal Bangalore, Madhuri Devabhaktuni
core  

A Diagnostic Pitfall of Primary Aldosteronism Presenting as Recurrent Quadriparesis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Quadriparesis refers to weakness affecting all four limbs. While most cases are neurogenic in origin, stemming from central or peripheral nervous system pathology, non‐neurogenic causes are less common and often under‐recognized. These include systemic or metabolic conditions that secondarily impair neuromuscular function.
Javed Shakir   +7 more
wiley   +1 more source

L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure

open access: yesClinical and Experimental Hypertension
Amlodipine has been used as a front-line anti-hypertensive therapy for decades by virtue of blocking voltage-operated calcium channels with high affinity and specificity.
Gary S. Bird   +6 more
doaj   +1 more source

Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers

open access: yes, 2007
Amlodipine, marketed primarily as a besylate salt, is a calcium channel blocker used for treating essential hypertension. Amlodipine maleate is another salt that is considered, in terms of pharmacokinetics and pharmacodynamics, similar to amlodipine ...
AMENTA, Francesco   +3 more
core  

An Unusual Cause of Diffuse Bone Pain in a Long‐Term Dialysis Patient: A Case Report of β2‐Microglobulin Amyloid Arthropathy

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Dialysis‐related amyloidosis (DRA) results from β2‐microglobulin accumulation in patients on long‐term hemodialysis, typically manifesting after 5–10 years. While well‐documented in developed countries, reports from sub‐Saharan Africa remain scarce.
Yannick Laurent Tchenadoyo Bayala   +8 more
wiley   +1 more source

Amlodipine Ameliorates Up-Regulation of ET-1 in Left Ventricle of Hypercholesterolemia Rabbits [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2010
Objective(s)In addition to antihypertensive effects, amlodipine may exhibit cardiovascular protective effects in heart tissue. The aim of this study was to evaluate the effects of amlodipine and/or high cholesterol diet on blood, heart tissue ...
Iraj Salehi   +3 more
doaj  

Strategic Reform for the Non‐Communicable Disease Crisis in Bangladesh: A Narrative Review of Policy Drivers and Systemic Solutions

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Bangladesh is experiencing a critical epidemiological shift, with non‐communicable diseases (NCDs) now accounting for nearly 67% of all deaths nationwide. These diseases, including cardiovascular conditions and diabetes, driven by unregulated urban growth, poor dietary habits, and sedentary lifestyles, pose a major threat ...
Abdullaha Al Mamun
wiley   +1 more source

Home - About - Disclaimer - Privacy